NCT05317299 is a NA clinical trial of 3 different type of exercise in Healthy, sponsored by Dilara Özen Oruk.

Who is sponsoring NCT05317299?

NCT05317299 is sponsored by Dilara Özen Oruk.

What drugs are being tested in NCT05317299?

Interventions in NCT05317299: 3 different type of exercise.

Is NCT05317299 still recruiting?

NCT05317299 is currently completed. Last updated 29 September 2023.

Last reviewed 2023-09-29 · How we verify

NCT05317299

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of the Effects of Different Exercise Types

Completed NA Last updated 29 September 2023

What this trial tests

NA trial testing 3 different type of exercise in Healthy in 65 participants. Completed in 30 July 2023.

Timeline

1 May 2022

Primary endpoint
30 July 2022

30 July 2023

Quick facts

Lead sponsor	Dilara Özen Oruk
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	65
Start date	1 May 2022
Primary completion	30 July 2022
Estimated completion	30 July 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

3 different type of exercise

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Dilara Özen Oruk

Who can join

Adults 18 to 30, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study perform to investigate the comparison of the effects of different exercise types on lower extremity muscle thickness, tendon thickness, muscle strength, proprioception and balance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Dilara Özen Oruk trials

Trials by the same sponsor.

NCT05293782 — The Effect of Trunk Kinesio Taping on Trunk Strength, Trunk Endurance, Balance and Plantar Pressure · NA · unknown
NCT05294224 — The Relationship Between Disease Severity and Various Lower Extremity Parameters in Individuals With Knee Osteoarthritis · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05317299 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dilara Özen Oruk
Last refreshed: 29 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05317299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing